Long intergenic non-protein coding RNA 1118 (LINC01118)

Long intergenic non-protein coding RNA 1118 (LINC01118) is a human long non-coding RNA (lncRNA), specifically a long intergenic non-coding RNA (lincRNA), that does not encode a protein but can regulate gene expression through epigenetic and chromatin-related mechanisms[1][5][9]. LINC01118 has been identified as highly expressed in human oocytes at the metaphase II stage, suggesting potential involvement in chromatin remodeling, cellular pluripotency, and early embryonic development[3]. Like other lincRNAs, it may participate in transcriptional and epigenetic regulation by interacting with chromatin modifiers or acting as scaffolds for assembling protein complexes relevant to gene regulation[5][7]. There is currently minimal evidence linking LINC01118 directly to specific diseases, drug targets, or established therapeutic pathways, though it has been proposed as a biomarker for oocyte quality in reproductive medicine[3]. Note: - LINC01118 is not a canonical therapeutic target (such as a receptor, enzyme, transporter, or transcription factor), but rather a regulatory RNA with emerging functional annotation. - There is no evidence from current resources that LINC01118 is directly involved in disease pathogenesis or subject to direct pharmacological targeting[1][3][5][7].

Other names

LINC01119LOC124906004LINC01118